JP2020078318A5 - - Google Patents

Download PDF

Info

Publication number
JP2020078318A5
JP2020078318A5 JP2020015937A JP2020015937A JP2020078318A5 JP 2020078318 A5 JP2020078318 A5 JP 2020078318A5 JP 2020015937 A JP2020015937 A JP 2020015937A JP 2020015937 A JP2020015937 A JP 2020015937A JP 2020078318 A5 JP2020078318 A5 JP 2020078318A5
Authority
JP
Japan
Prior art keywords
isfahan
virus
antigen
protein
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020015937A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020078318A (ja
JP7454393B2 (ja
Filing date
Publication date
Priority claimed from JP2016555578A external-priority patent/JP2017508465A/ja
Application filed filed Critical
Publication of JP2020078318A publication Critical patent/JP2020078318A/ja
Publication of JP2020078318A5 publication Critical patent/JP2020078318A5/ja
Priority to JP2022095401A priority Critical patent/JP2022126723A/ja
Application granted granted Critical
Publication of JP7454393B2 publication Critical patent/JP7454393B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020015937A 2014-03-01 2020-02-03 組換えイスファハンウイルスベクター Active JP7454393B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022095401A JP2022126723A (ja) 2014-03-01 2022-06-14 組換えイスファハンウイルスベクター

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461946734P 2014-03-01 2014-03-01
US61/946,734 2014-03-01
JP2016555578A JP2017508465A (ja) 2014-03-01 2015-02-27 組換えイスファハンウイルスベクター

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016555578A Division JP2017508465A (ja) 2014-03-01 2015-02-27 組換えイスファハンウイルスベクター

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022095401A Division JP2022126723A (ja) 2014-03-01 2022-06-14 組換えイスファハンウイルスベクター

Publications (3)

Publication Number Publication Date
JP2020078318A JP2020078318A (ja) 2020-05-28
JP2020078318A5 true JP2020078318A5 (cg-RX-API-DMAC10.html) 2021-03-18
JP7454393B2 JP7454393B2 (ja) 2024-03-22

Family

ID=54055975

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016555578A Pending JP2017508465A (ja) 2014-03-01 2015-02-27 組換えイスファハンウイルスベクター
JP2020015937A Active JP7454393B2 (ja) 2014-03-01 2020-02-03 組換えイスファハンウイルスベクター
JP2022095401A Pending JP2022126723A (ja) 2014-03-01 2022-06-14 組換えイスファハンウイルスベクター

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2016555578A Pending JP2017508465A (ja) 2014-03-01 2015-02-27 組換えイスファハンウイルスベクター

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022095401A Pending JP2022126723A (ja) 2014-03-01 2022-06-14 組換えイスファハンウイルスベクター

Country Status (14)

Country Link
US (1) US9932564B2 (cg-RX-API-DMAC10.html)
EP (1) EP3113795B1 (cg-RX-API-DMAC10.html)
JP (3) JP2017508465A (cg-RX-API-DMAC10.html)
KR (1) KR102416194B1 (cg-RX-API-DMAC10.html)
CN (1) CN106794240A (cg-RX-API-DMAC10.html)
AU (1) AU2015225553B2 (cg-RX-API-DMAC10.html)
CA (1) CA2941261A1 (cg-RX-API-DMAC10.html)
DK (1) DK3113795T3 (cg-RX-API-DMAC10.html)
ES (1) ES2749381T3 (cg-RX-API-DMAC10.html)
IL (2) IL247545B (cg-RX-API-DMAC10.html)
MX (1) MX369776B (cg-RX-API-DMAC10.html)
SG (1) SG11201607287XA (cg-RX-API-DMAC10.html)
WO (1) WO2015134332A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA201606036B (cg-RX-API-DMAC10.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11364292B2 (en) 2015-07-21 2022-06-21 Modernatx, Inc. CHIKV RNA vaccines
WO2017070624A1 (en) 2015-10-22 2017-04-27 Modernatx, Inc. Tropical disease vaccines
MA49421A (fr) 2017-06-15 2020-04-22 Modernatx Inc Formulations d'arn
MX2020002348A (es) 2017-08-31 2020-10-08 Modernatx Inc Métodos de elaboración de nanopartículas lipídicas.
EP3681514A4 (en) 2017-09-14 2021-07-14 ModernaTX, Inc. RNA VACZINE AGAINST ZIKA VIRUS
EP3681523A4 (en) * 2017-09-15 2021-12-29 The Ohio State Innovation Foundation Vaccines and methods of making and using vaccines for prevention of respiratory syncytial virus (rsv) infections
EP3823654B1 (en) * 2018-07-17 2024-02-14 Yale University Methods for treatment of cancer using chikungunya-vsv chimeric virus
US12090235B2 (en) 2018-09-20 2024-09-17 Modernatx, Inc. Preparation of lipid nanoparticles and methods of administration thereof
CN113939282A (zh) 2019-01-31 2022-01-14 摩登纳特斯有限公司 制备脂质纳米颗粒的方法
MA55321A (fr) 2019-03-15 2022-01-19 Modernatx Inc Vaccins à base d'arn contre le vih
CN115612674B (zh) * 2021-07-14 2026-01-30 上海荣瑞医药科技有限公司 一种溶瘤病毒及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7153510B1 (en) * 1995-05-04 2006-12-26 Yale University Recombinant vesiculoviruses and their uses
ATE468859T1 (de) 2003-03-26 2010-06-15 Wyeth Llc Immunogene zusammensetzung und verfahren
CN101087886B (zh) * 2004-04-09 2013-07-17 惠氏公司 疱疹性口炎病毒、其载体和其免疫原性组合物的协同减毒
EP1756287B1 (en) * 2004-04-09 2015-02-25 Wyeth LLC Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof
WO2009016433A2 (en) * 2006-09-15 2009-02-05 Ottawa Health Research Institute Oncolytic rhabdovirus
ES2708856T3 (es) * 2007-08-03 2019-04-11 Pasteur Institut Vectores de transferencia de gen lentivírico y sus aplicaciones medicinales
WO2009114207A2 (en) * 2008-03-14 2009-09-17 Sanofi Pasteur Biologics Co. Replication-defective flavivirus vaccines and vaccine vectors
WO2010105347A1 (en) * 2009-03-16 2010-09-23 Mcmaster University Vaccination methods
KR101723900B1 (ko) * 2009-06-08 2017-04-07 더 유니버시티 오브 웨스트 온타리오 면역화 요법용 발현 벡터로서의 수포성 구내염 바이러스의 상이한 혈청형
PT3351636T (pt) * 2010-05-14 2020-09-24 Univ Oregon Health & Science Vectores de hcmv e rhcmv recombinantes codificadores de um antigénio heterólogo isolado a partir de um vírus paramyxoviridae e seus usos
US20130095556A1 (en) * 2011-09-21 2013-04-18 International Aids Vaccine Initiative Novel vesicular stomatitis virus and virus rescue system

Similar Documents

Publication Publication Date Title
US10646557B2 (en) Vaccine composition
Cohen et al. Modulating the immune response to genetic immunization
AU2017297610B2 (en) Compositions and methods for alphavirus vaccination
Chattergoon Genetic immunization: a new era in vaccines and immune therapeutics
JP2019526580A5 (cg-RX-API-DMAC10.html)
US9630996B2 (en) Attenuated recombinant vesicular stomatitis viruses comprising modified mutant matrix proteins
WO2015106697A1 (zh) 免疫增强的人乳头瘤病毒感染及相关疾病的治疗性疫苗
JP2010500399A5 (cg-RX-API-DMAC10.html)
JP2008508866A5 (cg-RX-API-DMAC10.html)
JP2016128513A5 (cg-RX-API-DMAC10.html)
JP2008530245A5 (cg-RX-API-DMAC10.html)
WO2003031602A1 (en) The oncolytic microorganisms expressing hsp and uses thereof
JP2006523224A (ja) 免疫原性組成物および方法
CN105906721A (zh) 一种水痘-带状疱疹病毒gB-gE-gH-gL融合蛋白、基因工程亚单位疫苗及制备方法
JP2025094154A5 (cg-RX-API-DMAC10.html)
CN113226364A (zh) 组合物和方法
JP2024544566A5 (cg-RX-API-DMAC10.html)
Gupta et al. Vaccination with a fusion protein that introduces HIV-1 gag antigen into a multitrimer CD40L construct results in enhanced CD8+ T cell responses and protection from viral challenge by vaccinia-gag
US11160857B2 (en) Multivalent enterovirus vaccine compositions and uses related thereto
RU2015121429A (ru) Химерные антигены для вакцины против вируса гепатита с
WO2025081515A1 (zh) 一种特异性标记异源蛋白的肿瘤新抗原疫苗体系及其应用
CN104744594B (zh) 乙肝病毒多表位与志贺毒素的融合蛋白及其制备方法和应用
CN105198982A (zh) 基于il-6的抗原表位及其应用
Xie et al. Co-administration of antigen with chemokine MCP-3 or MDC/CCL22 enhances DNA vaccine potency
WO2007093134A1 (en) Aids vaccine based on replicative vaccinia virus vector